Da remiziramo...
Page 31 of 50
Page 31 of 50 • 1 ... 17 ... 30, 31, 32 ... 40 ... 50
Re: Da remiziramo...
Dekan Katoličkog fakulteta: Oxfordsko i rusko cjepivo nisu etički prihvatljivi
U EMISIJI Argumenti Hrvatskoga katoličkog radija u ponedjeljak 14. prosinca razgovaralo se o stavu Katoličke crkve prema cijepljenju.
Rekao da neka cjepiva nisu etički prihvatljiva
Dugalić je istaknuo da treba dobro razlikovati koja su cjepiva etički prihvatljiva, a koja ne.
"Iz onoga što sada raspolažemo i ono što pokazuju znanstvene studije saznajemo da neka cjepiva, primjerice oxfordsko pa i rusko i kinesko, nisu etički prihvatljiva. Crkva jest za cijepljenje i to je razborita odluka, ali pri tome ćemo trebati voditi računa s kojim cjepivom se cijepimo. Moramo znati je li to cjepivo etički prihvatljivo ili ne", rekao je.
Kaić je pojasnio da će u Hrvatsku stići Pfizerovo i Modernino cjepivo. To su messenger RNK cjepiva i nabavljena su dva cjepiva na adenovirusnom vektoru. "Što se etičnosti tiče, rekao bih kako ova messenger RNK cjepiva nisu uzgajana ni na kakvim staničnim kulturama, nego su sintetizirana, a adenovirusna cjepiva jesu uzgajana na staničnim kulturama koje imaju porijeklo u embrionima stanicama", rekao je.
https://www.index.hr/vijesti/clanak/dekan-katolickog-fakulteta-neka-cjepiva-nisu-eticki-prihvatljiva/2239203.aspx
toooooooo... čobane nek ti krepa cijelo stado sve ovce i jaganjčad boli te kurac.
U EMISIJI Argumenti Hrvatskoga katoličkog radija u ponedjeljak 14. prosinca razgovaralo se o stavu Katoličke crkve prema cijepljenju.
Rekao da neka cjepiva nisu etički prihvatljiva
Dugalić je istaknuo da treba dobro razlikovati koja su cjepiva etički prihvatljiva, a koja ne.
"Iz onoga što sada raspolažemo i ono što pokazuju znanstvene studije saznajemo da neka cjepiva, primjerice oxfordsko pa i rusko i kinesko, nisu etički prihvatljiva. Crkva jest za cijepljenje i to je razborita odluka, ali pri tome ćemo trebati voditi računa s kojim cjepivom se cijepimo. Moramo znati je li to cjepivo etički prihvatljivo ili ne", rekao je.
Kaić je pojasnio da će u Hrvatsku stići Pfizerovo i Modernino cjepivo. To su messenger RNK cjepiva i nabavljena su dva cjepiva na adenovirusnom vektoru. "Što se etičnosti tiče, rekao bih kako ova messenger RNK cjepiva nisu uzgajana ni na kakvim staničnim kulturama, nego su sintetizirana, a adenovirusna cjepiva jesu uzgajana na staničnim kulturama koje imaju porijeklo u embrionima stanicama", rekao je.
https://www.index.hr/vijesti/clanak/dekan-katolickog-fakulteta-neka-cjepiva-nisu-eticki-prihvatljiva/2239203.aspx
toooooooo... čobane nek ti krepa cijelo stado sve ovce i jaganjčad boli te kurac.
Guest- Guest
Re: Da remiziramo...
Šta misliš dokle će ljudima mazat oči, fotošopirat i zamućivat snimke i dr. ?
_________________
T.- Posts : 17558
2014-04-14
Age : 83
Re: Da remiziramo...
REGISTRACIJA UOČI BOŽIĆA
Prva osoba u Hrvatskoj primit će cjepivo 28. prosinca? Capak nam je otkrio najnovije planove
Pfizerovo cjepivo trebalo bi odobrenje za upotrebu u EU dobiti 23. prosinca. Nijemci s cijepljenjem kreću na Štefanje
https://www.jutarnji.hr/vijesti/hrvatska/prva-osoba-u-hrvatskoj-primit-ce-cjepivo-28-prosinca-capak-nam-je-otkrio-najnovije-planove-15015628
Ujmeissovo.
Prva osoba u Hrvatskoj primit će cjepivo 28. prosinca? Capak nam je otkrio najnovije planove
Pfizerovo cjepivo trebalo bi odobrenje za upotrebu u EU dobiti 23. prosinca. Nijemci s cijepljenjem kreću na Štefanje
https://www.jutarnji.hr/vijesti/hrvatska/prva-osoba-u-hrvatskoj-primit-ce-cjepivo-28-prosinca-capak-nam-je-otkrio-najnovije-planove-15015628
Ujmeissovo.
_________________
Nulla rosa sine spina
Eroo- Posts : 78957
2016-07-22
Re: Da remiziramo...
Eroo wrote:REGISTRACIJA UOČI BOŽIĆA
Prva osoba u Hrvatskoj primit će cjepivo 28. prosinca? Capak nam je otkrio najnovije planove
Pfizerovo cjepivo trebalo bi odobrenje za upotrebu u EU dobiti 23. prosinca. Nijemci s cijepljenjem kreću na Štefanje
https://www.jutarnji.hr/vijesti/hrvatska/prva-osoba-u-hrvatskoj-primit-ce-cjepivo-28-prosinca-capak-nam-je-otkrio-najnovije-planove-15015628
Ujmeissovo.
ajmo propaganda na najjače jebeš cajke više.
Guest- Guest
Re: Da remiziramo...
Širi kontekst, u koji sam ugrubo crtkano ucrtao planirani
budući put prema gore - Mt Sharp.
budući put prema gore - Mt Sharp.
_________________
Nulla rosa sine spina
Eroo- Posts : 78957
2016-07-22
Re: Da remiziramo...
Za normalne ljude nepotrebna, a za ravnozemlješe je besmislena.Gnječ wrote:Eroo wrote:Prva osoba u Hrvatskoj primit će cjepivo 28. prosinca? Capak nam je otkrio najnovije planove
Pfizerovo cjepivo trebalo bi odobrenje za upotrebu u EU dobiti 23. prosinca. Nijemci s cijepljenjem kreću na Štefanje
https://www.jutarnji.hr/vijesti/hrvatska/prva-osoba-u-hrvatskoj-primit-ce-cjepivo-28-prosinca-capak-nam-je-otkrio-najnovije-planove-15015628
Ujmeissovo.
ajmo propaganda na najjače jebeš cajke više.
_________________
Nulla rosa sine spina
Eroo- Posts : 78957
2016-07-22
Re: Da remiziramo...
Brnjičari su oni koji neće "brnjice", mjere, zemlja je ravna...to ti je toRa wrote:Onda sam nešto krivo shvatila.Noor wrote:jok...to mutavi, strina & Co.Ra wrote:Brnjičarka?Noor wrote:U Njemačkoj Ausweis bis zum Lidl und zuruck
To uvest u Splitu
Mislila sam da brnjičari navijaju za maske (brnjice), a ravnozemljaši negiraju postojanje korone.
_________________
It's So Good To Be Bad
Noor- Posts : 25907
2017-10-06
Re: Da remiziramo...
Eroo wrote:Za normalne ljude nepotrebna, a za ravnozemlješe je besmislena.Gnječ wrote:Eroo wrote:Prva osoba u Hrvatskoj primit će cjepivo 28. prosinca? Capak nam je otkrio najnovije planove
Pfizerovo cjepivo trebalo bi odobrenje za upotrebu u EU dobiti 23. prosinca. Nijemci s cijepljenjem kreću na Štefanje
https://www.jutarnji.hr/vijesti/hrvatska/prva-osoba-u-hrvatskoj-primit-ce-cjepivo-28-prosinca-capak-nam-je-otkrio-najnovije-planove-15015628
Ujmeissovo.
ajmo propaganda na najjače jebeš cajke više.
ajd dobro jebote ti si zaostao u emocionalnom mentalnom razvoju u dobi razmaženog derišta od 5 ili 7 godina starosti to se vidi i sa Marsa naravno ti to ne vidiš jer ti je za takve stvari oko ko u ćorave kokoši a ne u sokola.
to što si tu nakeljio je spin propaganda. kažeš stiglo cjepivo za jednog prvog pacijenta ko da si rekao stigla žlica vode za 4.5 milijuna ljudi koji kubure žedni u pustinji.
eto. sad ti lupetaj dalje.
Guest- Guest
Re: Da remiziramo...
Tako je, ravnozemljaši iliti brnjičari su jedno te isto. Deset puta dnevno min. izgovore da neće brnjicu. Cijepivo isto neće jer će im promjeniti genetski kod pa neće više biti ljudi- majmuni kao do sada . Truju ih chemtrailsima ljudi zlih namjera u sjeni. Korona je gripa i čude se što umrlima nisu dali sumamed jer misle da u tom slučaju ne bi umrli. Preporučuju i zink pastile i rade obdukciju preko neta pa su sigurni da nitko nije umro od korone nego sa koronom.Noor wrote:Brnjičari su oni koji neće "brnjice", mjere, zemlja je ravna...to ti je toRa wrote:Onda sam nešto krivo shvatila.Noor wrote:jok...to mutavi, strina & Co.Ra wrote:Brnjičarka?Noor wrote:U Njemačkoj Ausweis bis zum Lidl und zuruck
To uvest u Splitu
Mislila sam da brnjičari navijaju za maske (brnjice), a ravnozemljaši negiraju postojanje korone.
Nemoš im nikako objasniti da im jesu dali sumamed i još štošta al ništa.
I općenito i bog je od njih digao ruke.
kaya- Posts : 31419
2015-08-15
Re: Da remiziramo...
ima još jedno cjepivo za covid-19 koje istražuju norvežani i britanci zajedno. možda bude u opticaju a možda i ne zove se Biovacc-19 njega nećete naći nigdje na googlu i drugim tražilicama nitko u medijima ne piše o toj vakcini jer nakon onoga što su virolozi otkrili cijela svjetska medicinska struka se agresivno obrušila na njih ne bi li ih diskreditirali i ušutkali. uspjeli su ali nešto još postoji na netu pa sam iskopao. dakle ti su virolozi išli totalno drugim putem za dobiti vakcinu a to je da su dešifrirali kako virus funkcionira tj etiologiju virusa kako je taj virus zapravo nastao.
pa su tako reverse ingeneering došli do neoborivih dokaza da je Sars-CoV-2 ustvari chimera virus odnosno sintetički virus iskemijan u laboratoriju.
ja ću ovdje staviti linkove na stručne radove gdje norveški virolozi detaljno objašnjavaju kako je Sars-CoV-2 virus sintetiziran, ima dosta za čitati ima hi-res fotografija za lakše snalaženje i razumijevanje pa koga zanima nek izvoli. ja sam to sve sejvao za slučaj da literatura nestane sa neta.
Biovacc-19: a controversial candidate vaccine
A Norwegian-British study has stirred up once more the debate about the origins of the SARS-CoV-2 virus. The article, which appeared in QRB Discovery, describes the development of the rationale behind the Biovacc-19 development. Biovacc-19 does not follow any of the 8 more conventional vaccine design routes recently summarized in Nature. The authors stress the importance of an approach starting from understanding the etiology of the virus. Not doing so might result in ineffective or even harmful vaccines.
The researchers claim that the virus’ RNA sequence has elements which are artificially inserted. Moreover, the lack of mutation of the virus since the moment it began to infect humans is seen as a further indication that it was already adapted to humans.
The results landed in the public eye after former MI6 chief Sir Richard Dearlove saw here new evidence that the virus was man-made. He conjectured that the outbreak had started with an accidental leak from a Chinese laboratory.
The work has immediately met with severe criticism by colleagues. The inserted sequences identified as artificial are not unusual in nature, as examples can be found in other viruses such as HIV and various types of influenza. In addition, there have been several publications showing evolution and mutation among SARS-CoV-2 strains. In summary: all what you would expect from a purely natural, non-synthetic source.
And the doom scenario depicted for conventional vaccine routes? Several vaccines already tested on humans seem to be able of triggering the immune system’s response. All in all, reason for some cautious optimism.
https://the-corona-diaries.com/biovacc-19-a-controversial-candidate-vaccine/
Norwegian virologist claims coronavirus is 'chimera' made in Chinese lab
British-Norwegian study alleges COVID-19 has 'inserted sections'
A joint British-Norwegian study alleges that the Wuhan coronavirus (COVID-19) is a "chimera" constructed in a Chinese lab.
A study, authored by University of London Professor Angus Dalgleish and Norwegian virologist Birger Sorensen and published in Cambridge University's QRB Discovery, claims that Sars-CoV2, the virus that causes COVID-19, did not evolve naturally but rather was artificially manipulated. Specifically, the authors allege that the spike proteins of the virus contain "inserted sections."
The study's authors also pointed out that the virus has hardly mutated since it began to infect humans, apparently suggesting that it was already fully adapted to human biology in the laboratory. Sorensen told Norway's NRK on Monday (June 8) that this is "quite unusual for viruses that cross species barriers."
He added that the virus has properties that differ greatly from SARS and "which have never been detected in nature." After carefully examining the genetic sequence of the virus, he said that it did not appear to have evolved from natural processes.
Sorenson told the news agency that he believes the virus is related to a number of "gain of function studies" being carried out in China. He also said that the U.S. and China had been collaborating on such research in advanced labs for many years.
The purpose of the gain of function studies is to artificially increase the transmissibility of a virus to make it easier to repeat scientific experiments quickly. Such manipulated viruses are referred to as "chimera."
Sorensen claims that at the early stages of the outbreak, Chinese scientists discussed the modified sequences in the virus. However, he said he believes that in recent months, the Chinese government has suppressed all public discourse on the subject.
"The inserted sequences should never have been published. Had it been today, it would never have happened. It was a big mistake the Chinese made. The inserted sequences have a functionality that we describe. We explain why they are essential. But the Chinese pointed to them first."
https://www.taiwannews.com.tw/en/news/3945654
Biovacc-19: A Candidate Vaccine for Covid-19 (SARS-CoV-2) Developed from Analysis of its General Method of Action for Infectivity
Abstract
This study presents the background, rationale and method of action of Biovacc-19, a candidate vaccine for corona virus disease 2019 (Covid-19), now in advanced preclinical development, which has already passed the first acute toxicity testing. Unlike conventionally developed vaccines, Biovacc-19’s method of operation is upon nonhuman-like (NHL) epitopes in 21.6% of the composition of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)’s spike protein, which displays distinct distributed charge including the presence of a charged furin-like cleavage site. The logic of the design of the vaccine is explained, which starts with empirical analysis of the aetiology of SARS-CoV-2. Mistaken assumptions about SARS-CoV-2’s aetiology risk creating ineffective or actively harmful vaccines, including the risk of antibody-dependent enhancement. Such problems in vaccine design are illustrated from past experience in the human immunodeficiency viruses domain. We propose that the dual effect general method of action of this chimeric virus’s spike, including receptor binding domain, includes membrane components other than the angiotensin-converting enzyme 2 receptor, which explains clinical evidence of its infectivity and pathogenicity. We show the nonreceptor dependent phagocytic general method of action to be specifically related to cumulative charge from insertions placed on the SARS-CoV-2 spike surface in positions to bind efficiently by salt bridge formations; and from blasting the spike we display the NHL epitopes from which Biovacc-19 has been down-selected.
Fig. 1 shows six alignments with inserts. The first five inserts are pointed out by (Zhou et al., 2020) and located near/around position 72, 150, 250, 445 and 471, respectively, whereas the insert around 680 is pointed out by (Coutard et al., 2020) as a furin-like cleavage site with cleavage between R and S. Apart from inserts 4 and 5, these inserts are all basic inserts. The red arrows point out the basic amino acids. The green arrow and line point out the furin-like cleavage site.
It has been recently suggested that new X-Ray crystallography can assist in one of our key investigations: the docking of spike with receptor. (Shang et al., 2020) Unfortunately, we cannot agree. The Nature paper entitled ‘Structural basis of receptor recognition by SARS-CoV-2’ does not, in fact, represent a true structure of the spike SARS-CoV-2 trimer apart from a modified part of the receptor binding motif (RBM). It uses the structure and the sequence for SARS-CoV deposited on 1 August 2005 as the backbone and then creates a chimera with the RBM (437–508) of SARS-CoV-2 modified and inserted. This is a confusing structural determination, representing neither virus. The authors were keen to focus on the importance of the ACE-2 receptor: ‘we improved the ACE2-binding affinity of the chimeric RBD by keeping a short loop from the SARS-CoV RBM’. But then four of the six new charged inserts (1, 2, 3 and 6) outside the RBM were also excluded from their chimera, and the Cov-2 specific Cys538–Cys590 bridge which brings in additional charge from 526–560 (with pI = 10.03) via the Cys391–Cys525 right next to the RBM.
By these excisions the very essence of the novel structure and functionalities of SARS-Cov-2, and hence of its general mode of action for infectivity, is obscured. Therefore, using this structure from this paper would be quite misleading.
The SARS-CoV-2 3D structures have been usefully determined for SARS-CoV-2 trimer spike protein by (Walls et al., 2020).
Our findings confirm (Coutard et al., 2020) that the SARS-CoV-2 contains a furin-like cleavage site absent in CoV of the same clade. Also in Fig. 1, Coutard highlight that enriched basic charge associated with this cleavage site are found in a number of viruses such as HIV, influenza, human CytoMegalo virus (Herpes) and respiratory syncytial virus, yellow fever, zika and ebola. Coutard et al. (2020) furthermore state that, ‘conversely, the highly pathogenic forms of influenza have a furin-like cleavage site cleaved by different cellular proteases, including furin, which are expressed in a wide variety of cell types allowing a widening of the cell tropism of the virus’. Furthermore, the insertion of a multibasic motif RERRRKKR↓GL at the H5N1 hemagglutinin HA cleavage site was likely associated with the hyper-virulence of the virus during the Hong Kong 1997 outbreak. Extensive clinical evidence in this pandemic suggests that SARS-CoV-2 poses such widened cell tropism.
https://www.cambridge.org/core/journals/qrb-discovery/article/biovacc19-a-candidate-vaccine-for-covid19-sarscov2-developed-from-analysis-of-its-general-method-of-action-for-infectivity/DBBC0FA6E3763B0067CAAD8F3363E527
pa su tako reverse ingeneering došli do neoborivih dokaza da je Sars-CoV-2 ustvari chimera virus odnosno sintetički virus iskemijan u laboratoriju.
ja ću ovdje staviti linkove na stručne radove gdje norveški virolozi detaljno objašnjavaju kako je Sars-CoV-2 virus sintetiziran, ima dosta za čitati ima hi-res fotografija za lakše snalaženje i razumijevanje pa koga zanima nek izvoli. ja sam to sve sejvao za slučaj da literatura nestane sa neta.
Biovacc-19: a controversial candidate vaccine
A Norwegian-British study has stirred up once more the debate about the origins of the SARS-CoV-2 virus. The article, which appeared in QRB Discovery, describes the development of the rationale behind the Biovacc-19 development. Biovacc-19 does not follow any of the 8 more conventional vaccine design routes recently summarized in Nature. The authors stress the importance of an approach starting from understanding the etiology of the virus. Not doing so might result in ineffective or even harmful vaccines.
The researchers claim that the virus’ RNA sequence has elements which are artificially inserted. Moreover, the lack of mutation of the virus since the moment it began to infect humans is seen as a further indication that it was already adapted to humans.
The results landed in the public eye after former MI6 chief Sir Richard Dearlove saw here new evidence that the virus was man-made. He conjectured that the outbreak had started with an accidental leak from a Chinese laboratory.
The work has immediately met with severe criticism by colleagues. The inserted sequences identified as artificial are not unusual in nature, as examples can be found in other viruses such as HIV and various types of influenza. In addition, there have been several publications showing evolution and mutation among SARS-CoV-2 strains. In summary: all what you would expect from a purely natural, non-synthetic source.
And the doom scenario depicted for conventional vaccine routes? Several vaccines already tested on humans seem to be able of triggering the immune system’s response. All in all, reason for some cautious optimism.
https://the-corona-diaries.com/biovacc-19-a-controversial-candidate-vaccine/
Norwegian virologist claims coronavirus is 'chimera' made in Chinese lab
British-Norwegian study alleges COVID-19 has 'inserted sections'
A joint British-Norwegian study alleges that the Wuhan coronavirus (COVID-19) is a "chimera" constructed in a Chinese lab.
A study, authored by University of London Professor Angus Dalgleish and Norwegian virologist Birger Sorensen and published in Cambridge University's QRB Discovery, claims that Sars-CoV2, the virus that causes COVID-19, did not evolve naturally but rather was artificially manipulated. Specifically, the authors allege that the spike proteins of the virus contain "inserted sections."
The study's authors also pointed out that the virus has hardly mutated since it began to infect humans, apparently suggesting that it was already fully adapted to human biology in the laboratory. Sorensen told Norway's NRK on Monday (June 8) that this is "quite unusual for viruses that cross species barriers."
He added that the virus has properties that differ greatly from SARS and "which have never been detected in nature." After carefully examining the genetic sequence of the virus, he said that it did not appear to have evolved from natural processes.
Sorenson told the news agency that he believes the virus is related to a number of "gain of function studies" being carried out in China. He also said that the U.S. and China had been collaborating on such research in advanced labs for many years.
The purpose of the gain of function studies is to artificially increase the transmissibility of a virus to make it easier to repeat scientific experiments quickly. Such manipulated viruses are referred to as "chimera."
Sorensen claims that at the early stages of the outbreak, Chinese scientists discussed the modified sequences in the virus. However, he said he believes that in recent months, the Chinese government has suppressed all public discourse on the subject.
"The inserted sequences should never have been published. Had it been today, it would never have happened. It was a big mistake the Chinese made. The inserted sequences have a functionality that we describe. We explain why they are essential. But the Chinese pointed to them first."
https://www.taiwannews.com.tw/en/news/3945654
Biovacc-19: A Candidate Vaccine for Covid-19 (SARS-CoV-2) Developed from Analysis of its General Method of Action for Infectivity
Abstract
This study presents the background, rationale and method of action of Biovacc-19, a candidate vaccine for corona virus disease 2019 (Covid-19), now in advanced preclinical development, which has already passed the first acute toxicity testing. Unlike conventionally developed vaccines, Biovacc-19’s method of operation is upon nonhuman-like (NHL) epitopes in 21.6% of the composition of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)’s spike protein, which displays distinct distributed charge including the presence of a charged furin-like cleavage site. The logic of the design of the vaccine is explained, which starts with empirical analysis of the aetiology of SARS-CoV-2. Mistaken assumptions about SARS-CoV-2’s aetiology risk creating ineffective or actively harmful vaccines, including the risk of antibody-dependent enhancement. Such problems in vaccine design are illustrated from past experience in the human immunodeficiency viruses domain. We propose that the dual effect general method of action of this chimeric virus’s spike, including receptor binding domain, includes membrane components other than the angiotensin-converting enzyme 2 receptor, which explains clinical evidence of its infectivity and pathogenicity. We show the nonreceptor dependent phagocytic general method of action to be specifically related to cumulative charge from insertions placed on the SARS-CoV-2 spike surface in positions to bind efficiently by salt bridge formations; and from blasting the spike we display the NHL epitopes from which Biovacc-19 has been down-selected.
Fig. 1 shows six alignments with inserts. The first five inserts are pointed out by (Zhou et al., 2020) and located near/around position 72, 150, 250, 445 and 471, respectively, whereas the insert around 680 is pointed out by (Coutard et al., 2020) as a furin-like cleavage site with cleavage between R and S. Apart from inserts 4 and 5, these inserts are all basic inserts. The red arrows point out the basic amino acids. The green arrow and line point out the furin-like cleavage site.
It has been recently suggested that new X-Ray crystallography can assist in one of our key investigations: the docking of spike with receptor. (Shang et al., 2020) Unfortunately, we cannot agree. The Nature paper entitled ‘Structural basis of receptor recognition by SARS-CoV-2’ does not, in fact, represent a true structure of the spike SARS-CoV-2 trimer apart from a modified part of the receptor binding motif (RBM). It uses the structure and the sequence for SARS-CoV deposited on 1 August 2005 as the backbone and then creates a chimera with the RBM (437–508) of SARS-CoV-2 modified and inserted. This is a confusing structural determination, representing neither virus. The authors were keen to focus on the importance of the ACE-2 receptor: ‘we improved the ACE2-binding affinity of the chimeric RBD by keeping a short loop from the SARS-CoV RBM’. But then four of the six new charged inserts (1, 2, 3 and 6) outside the RBM were also excluded from their chimera, and the Cov-2 specific Cys538–Cys590 bridge which brings in additional charge from 526–560 (with pI = 10.03) via the Cys391–Cys525 right next to the RBM.
By these excisions the very essence of the novel structure and functionalities of SARS-Cov-2, and hence of its general mode of action for infectivity, is obscured. Therefore, using this structure from this paper would be quite misleading.
The SARS-CoV-2 3D structures have been usefully determined for SARS-CoV-2 trimer spike protein by (Walls et al., 2020).
Our findings confirm (Coutard et al., 2020) that the SARS-CoV-2 contains a furin-like cleavage site absent in CoV of the same clade. Also in Fig. 1, Coutard highlight that enriched basic charge associated with this cleavage site are found in a number of viruses such as HIV, influenza, human CytoMegalo virus (Herpes) and respiratory syncytial virus, yellow fever, zika and ebola. Coutard et al. (2020) furthermore state that, ‘conversely, the highly pathogenic forms of influenza have a furin-like cleavage site cleaved by different cellular proteases, including furin, which are expressed in a wide variety of cell types allowing a widening of the cell tropism of the virus’. Furthermore, the insertion of a multibasic motif RERRRKKR↓GL at the H5N1 hemagglutinin HA cleavage site was likely associated with the hyper-virulence of the virus during the Hong Kong 1997 outbreak. Extensive clinical evidence in this pandemic suggests that SARS-CoV-2 poses such widened cell tropism.
https://www.cambridge.org/core/journals/qrb-discovery/article/biovacc19-a-candidate-vaccine-for-covid19-sarscov2-developed-from-analysis-of-its-general-method-of-action-for-infectivity/DBBC0FA6E3763B0067CAAD8F3363E527
Guest- Guest
Re: Da remiziramo...
Why we are researching the origins of SARS-CoV-2, biosafety labs and GOF research
In July 2020, U.S. Right to Know began submitting public records requests in pursuit of data from public institutions in an effort to discover what is known about the origins of the novel coronavirus SARS-CoV-2, which causes the disease Covid-19. Since the start of the outbreak in Wuhan, SARS-CoV-2 has killed over a million people, while sickening millions more in a global pandemic that continues to unfold.
We are also researching accidents, leaks and other mishaps at laboratories where pathogens of pandemic potential are stored and modified, and the public health risks of gain-of-function (GOF) research, which involves experiments to enhance aspects of the functionality of deadly pathogens, such as viral load, infectivity and transmissibility.
The public and global scientific community have a right to know what data exists about these matters. We will report here any useful findings that may emerge from our research.
U.S. Right to Know is an investigative research group focused on promoting transparency for public health.
Why are we conducting this research?
We are concerned that the national security apparatuses of the United States, China and elsewhere, and the university, industry and governmental entities with which they collaborate, may not provide a full and honest picture of the origins of SARS-CoV-2 and the dangers of gain-of-function research.
Through our research, we seek to answer three questions:
What is known about the origins of SARS-CoV-2?
Are there accidents or mishaps that have occurred at biosafety or GOF research facilities that have not been reported?
Are there concerns about ongoing safety risks of biosafety laboratories or GOF research that have not been reported?
What are the origins of SARS-CoV-2?
In late December 2019, in the city of Wuhan, China, news emerged of the deadly infectious disease called COVID-19, caused by SARS-CoV-2, a novel coronavirus that had not been known to exist before. The origins of SARS-CoV-2 are not known. There are two main hypotheses.
Researchers in professional networks associated with the Wuhan Institute of Virology (WIV) and EcoHealth Alliance, a U.S. non-profitthat has garnered millions of dollars from taxpayer-funded grants to collaborate with WIV on coronavirus research, have written that the novel virus likely originated via natural selection in animal hosts, with its reservoir in bats. This “zoonotic” origin hypothesis was further strengthened by claims that the new coronavirus outbreak started in a “wildlife” market in Wuhan, the Huanan seafood market, where potentially infected animals may have been sold. (However, at least one-third of the first cluster of infected patients, including the earliest known case of infection from December 1, 2019, had neither direct or indirect contact with the Huanan seafood market’s human and animal attendees.)
The zoonosis hypothesis is currently the prevailing hypothesis of origin. However, the zoonotic origin of SARS-CoV-2 has yet to be definitively established, and some researchers have pointed out that it rests upon contradictory observations that require further investigation.
https://usrtk.org/biohazards/why-we-are-researching-the-origins-of-sars-cov-2-biosafety-labs-and-gof-research/
In July 2020, U.S. Right to Know began submitting public records requests in pursuit of data from public institutions in an effort to discover what is known about the origins of the novel coronavirus SARS-CoV-2, which causes the disease Covid-19. Since the start of the outbreak in Wuhan, SARS-CoV-2 has killed over a million people, while sickening millions more in a global pandemic that continues to unfold.
We are also researching accidents, leaks and other mishaps at laboratories where pathogens of pandemic potential are stored and modified, and the public health risks of gain-of-function (GOF) research, which involves experiments to enhance aspects of the functionality of deadly pathogens, such as viral load, infectivity and transmissibility.
The public and global scientific community have a right to know what data exists about these matters. We will report here any useful findings that may emerge from our research.
U.S. Right to Know is an investigative research group focused on promoting transparency for public health.
Why are we conducting this research?
We are concerned that the national security apparatuses of the United States, China and elsewhere, and the university, industry and governmental entities with which they collaborate, may not provide a full and honest picture of the origins of SARS-CoV-2 and the dangers of gain-of-function research.
Through our research, we seek to answer three questions:
What is known about the origins of SARS-CoV-2?
Are there accidents or mishaps that have occurred at biosafety or GOF research facilities that have not been reported?
Are there concerns about ongoing safety risks of biosafety laboratories or GOF research that have not been reported?
What are the origins of SARS-CoV-2?
In late December 2019, in the city of Wuhan, China, news emerged of the deadly infectious disease called COVID-19, caused by SARS-CoV-2, a novel coronavirus that had not been known to exist before. The origins of SARS-CoV-2 are not known. There are two main hypotheses.
Researchers in professional networks associated with the Wuhan Institute of Virology (WIV) and EcoHealth Alliance, a U.S. non-profitthat has garnered millions of dollars from taxpayer-funded grants to collaborate with WIV on coronavirus research, have written that the novel virus likely originated via natural selection in animal hosts, with its reservoir in bats. This “zoonotic” origin hypothesis was further strengthened by claims that the new coronavirus outbreak started in a “wildlife” market in Wuhan, the Huanan seafood market, where potentially infected animals may have been sold. (However, at least one-third of the first cluster of infected patients, including the earliest known case of infection from December 1, 2019, had neither direct or indirect contact with the Huanan seafood market’s human and animal attendees.)
The zoonosis hypothesis is currently the prevailing hypothesis of origin. However, the zoonotic origin of SARS-CoV-2 has yet to be definitively established, and some researchers have pointed out that it rests upon contradictory observations that require further investigation.
https://usrtk.org/biohazards/why-we-are-researching-the-origins-of-sars-cov-2-biosafety-labs-and-gof-research/
Guest- Guest
Re: Da remiziramo...
a vidi ovo jebemti život ti jebem nađoh mailove raznih američkih virologa kako u početku pandemije pokušavaju zamuljati i dogovarati međusobno odakle je virus isplivao. te doktore i ostalu političku bagru treba uhapsiti i tužiti za zločin protiv čovječanstva. ameri su taj virus iskemijali zajedno sa Kinom Canadom i još kojom EU pripizdinom zato šute kao zaliveni.
https://usrtk.org/wp-content/uploads/2020/12/NASEM_Bedford-Email_Baric-1.pdf
https://usrtk.org/wp-content/uploads/2020/12/NASEM_Bedford-Email_Baric-1.pdf
Guest- Guest
veber-
Posts : 53509
2014-12-30
Re: Da remiziramo...
izmislilo pa ukraloGnječ wrote:a vidi ovo jebemti život ti jebem nađoh mailove raznih američkih virologa kako u početku pandemije pokušavaju zamuljati i dogovarati međusobno odakle je virus isplivao. te doktore i ostalu političku bagru treba uhapsiti i tužiti za zločin protiv čovječanstva. ameri su taj virus iskemijali zajedno sa Kinom Canadom i još kojom EU pripizdinom zato šute kao zaliveni.
https://usrtk.org/wp-content/uploads/2020/12/NASEM_Bedford-Email_Baric-1.pdf
debotoijusto- Posts : 31574
2014-04-12
Re: Da remiziramo...
[size=30]Istraživanje: Svaka četvrta osoba u svijetu možda neće dobiti cjepivo do 2022.[/size]
_________________
https://i.servimg.com/u/f25/20/30/76/79/flag-k10.jpg
"Snažni su duhom, njihova je vojska ustrajna jer brani svoju DOMOVINU"
michaellcmacha- Posts : 21325
2015-08-08
Re: Da remiziramo...
https://www.tportal.hr/vijesti/clanak/istrazivanje-svaka-cetvrta-osoba-u-svijetu-mozda-nece-dobiti-cjepivo-do-2022-foto-20201216michaellcmacha wrote:[size=45]Istraživanje: Svaka četvrta osoba u svijetu možda neće dobiti cjepivo do 2022.[/size]
michaellcmacha- Posts : 21325
2015-08-08
Re: Da remiziramo...
Znači 75% hoće. Di vidiš problem?michaellcmacha wrote:https://www.tportal.hr/vijesti/clanak/istrazivanje-svaka-cetvrta-osoba-u-svijetu-mozda-nece-dobiti-cjepivo-do-2022-foto-20201216michaellcmacha wrote:[size=45]Istraživanje: Svaka četvrta osoba u svijetu možda neće dobiti cjepivo do 2022.[/size]
Ako se do sredine 2021 prokuži 50% bit će dovoljno cijepiti 20%., što je ukupno imunizirano 70%.
Sve štima. Ja ovo na'prste izračuna...
_________________
Nulla rosa sine spina
Eroo- Posts : 78957
2016-07-22
Re: Da remiziramo...
Epidemiologinja Petrović: Cjepiva neće biti puno na raspolaganju, dolazit će sporo
EPIDEMIOLOGINJA Goranka Petrović, voditeljica Odjela za respiratorne bolesti Hrvatskog zavoda za javno zdravstvo, kazala je u emisiji HTV-a "Dobro jutro Hrvatska" da je razumljiv otpor ljudi prema novom cjepivu jer se radi o cjepivu koje je brzo razvijeno.
Dodala je kako se malo zna o samom virusu. Petrović je naglasila kako novog cjepiva neće biti puno na raspolaganju jer će dolaziti vrlo sporo tijekom sljedećih mjeseci.
"Zbog toga nam je jako važno da zaštitimo prvenstveno rizične skupine. Dakle, osobe koje imaju rizike razviti teške slike bolesti i završiti na bolničkom liječenju, pa, nažalost, imati i smrtni ishod", rekla je epidemiologinja.
Dodala je da sada imamo podatke o sigurnosti cjepiva te da je sigurnosni profil jako dobar.
"Međutim, sigurnosno praćenje osoba koje su primile cjepivo je dvije godine te će rezultati tada biti objavljeni. Ne očekujemo da se nakon par godina jave neke nuspojave, ali valja biti jako oprezan", naglasila je.
"No to je procjena za koju se ne zna koliko je točna, s obzirom na to da za sada nemamo podatke u kojoj mjeri cjepivo štiti od prijenosa, transmisije", rekla je.
EPIDEMIOLOGINJA Goranka Petrović, voditeljica Odjela za respiratorne bolesti Hrvatskog zavoda za javno zdravstvo, kazala je u emisiji HTV-a "Dobro jutro Hrvatska" da je razumljiv otpor ljudi prema novom cjepivu jer se radi o cjepivu koje je brzo razvijeno.
Dodala je kako se malo zna o samom virusu. Petrović je naglasila kako novog cjepiva neće biti puno na raspolaganju jer će dolaziti vrlo sporo tijekom sljedećih mjeseci.
"Zbog toga nam je jako važno da zaštitimo prvenstveno rizične skupine. Dakle, osobe koje imaju rizike razviti teške slike bolesti i završiti na bolničkom liječenju, pa, nažalost, imati i smrtni ishod", rekla je epidemiologinja.
"Cjepivo ne mijenja gene"
Komentirala je cjepivo Pfizera i Moderne te istaknula kako su ta cjepiva rađena relativno novim tehnologijama. Kazala je kako cjepivo ne mijenja naše gene.Dodala je da sada imamo podatke o sigurnosti cjepiva te da je sigurnosni profil jako dobar.
"Međutim, sigurnosno praćenje osoba koje su primile cjepivo je dvije godine te će rezultati tada biti objavljeni. Ne očekujemo da se nakon par godina jave neke nuspojave, ali valja biti jako oprezan", naglasila je.
"Dobra je odluka da je cijepljenje neobavezno"
Dodala je da će cjepiva, kao što su ona Pfizera i Moderne, kao i svaki novi lijek biti podvrgnuta tzv. postupku pojačanog praćenja. Naglasila je da je cijepljenje neobavezno te da je to dobra odluka. Istaknula je kako su procjene da treba cijepiti oko 70 posto stanovništva da bi se zaustavilo širenje zaraze virusom."No to je procjena za koju se ne zna koliko je točna, s obzirom na to da za sada nemamo podatke u kojoj mjeri cjepivo štiti od prijenosa, transmisije", rekla je.
vili40-
Posts : 11076
2015-08-02
Re: Da remiziramo...
First in-last out.Gnječ wrote:Eroo wrote:Za normalne ljude nepotrebna, a za ravnozemlješe je besmislena.Gnječ wrote:Eroo wrote:Prva osoba u Hrvatskoj primit će cjepivo 28. prosinca? Capak nam je otkrio najnovije planove
Pfizerovo cjepivo trebalo bi odobrenje za upotrebu u EU dobiti 23. prosinca. Nijemci s cijepljenjem kreću na Štefanje
https://www.jutarnji.hr/vijesti/hrvatska/prva-osoba-u-hrvatskoj-primit-ce-cjepivo-28-prosinca-capak-nam-je-otkrio-najnovije-planove-15015628
Ujmeissovo.
ajmo propaganda na najjače jebeš cajke više.
ajd dobro jebote ti si zaostao u emocionalnom mentalnom razvoju u dobi razmaženog derišta od 5 ili 7 godina starosti to se vidi i sa Marsa naravno ti to ne vidiš jer ti je za takve stvari oko ko u ćorave kokoši a ne u sokola.
to što si tu nakeljio je spin propaganda. kažeš stiglo cjepivo za jednog prvog pacijenta ko da si rekao stigla žlica vode za 4.5 milijuna ljudi koji kubure žedni u pustinji.
eto. sad ti lupetaj dalje.
_________________
Nulla rosa sine spina
Eroo- Posts : 78957
2016-07-22
Page 31 of 50 • 1 ... 17 ... 30, 31, 32 ... 40 ... 50
Page 31 of 50
Permissions in this forum:
You cannot reply to topics in this forum